Literature DB >> 7512027

Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes.

F Willems1, A Marchant, J P Delville, C Gérard, A Delvaux, T Velu, M de Boer, M Goldman.   

Abstract

There is evidence that interleukin -10(IL-10) interferes with the costimulatory properties of antigen-presenting cells and, thereby, inhibits their ability to induce T cell activation. To determine whether this effect might involve modulation of the expression of accessory molecules, we analyzed by flow cytometry the influence of human IL-10 on the basal expression of intercellular adhesion molecule 1 (ICAM-1) as well as on the interferon gamma (IFN-gamma)-induced up-regulation of ICAM-1 and B7 at the surface of human monocytes. IL-10 inhibited both the basal expression and the IFN-gamma-induced ICAM-1 up-regulation. IL-10 also reduced B7 up-regulation on IFN-gamma-stimulated monocytes. The inhibitory effect of IL-10 both on ICAM-1 and B7 expression was shown to be dose dependent. We conclude that the ability of IL-10 to decrease both ICAM-1 and B7 expression on monocytes might contribute to its immunosuppressive properties.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512027     DOI: 10.1002/eji.1830240435

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  84 in total

1.  Interleukin 10 treatment for rheumatoid arthritis.

Authors:  E W St Clair
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease.

Authors:  C Gasche; S Bakos; C Dejaco; W Tillinger; S Zakeri; W Reinisch
Journal:  J Clin Immunol       Date:  2000-09       Impact factor: 8.317

3.  IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection.

Authors:  Galit Alter; Daniel Kavanagh; Suzannah Rihn; Rutger Luteijn; David Brooks; Michael Oldstone; Jan van Lunzen; Marcus Altfeld
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

4.  Blockade of endogenous interleukin 12 results in suppression of murine streptococcal cell wall arthritis by enhancement of interleukin 10 and interleukin 1Ra.

Authors:  L A Joosten; M M Helsen; W B van Den Berg
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

Review 5.  IFN-γ: A cytokine at the right time, is in the right place.

Authors:  J Daniel Burke; Howard A Young
Journal:  Semin Immunol       Date:  2019-06-17       Impact factor: 11.130

6.  Two distinct pathways of human macrophage differentiation are mediated by interferon-gamma and interleukin-10.

Authors:  T Orlikowsky; T Olikowsky; Z Q Wang; A Dudhane; H Horowitz; B Conti; M K Hoffmann
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

7.  IL-10 augments CD23 expression on U937 cells and down-regulates IL-4-driven CD23 expression on cultured human blood monocytes: effects of IL-10 and other cytokines on cell phenotype and phagocytosis.

Authors:  A Spittler; C Schiller; M Willheim; C Tempfer; S Winkler; G Boltz-Nitulescu
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

8.  Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses.

Authors:  Claire Gorby; Junel Sotolongo Bellón; Stephan Wilmes; Walid Warda; Elizabeth Pohler; Paul K Fyfe; Adeline Cozzani; Christophe Ferrand; Mark R Walter; Suman Mitra; Jacob Piehler; Ignacio Moraga
Journal:  Sci Signal       Date:  2020-09-15       Impact factor: 8.192

9.  Vitamin D differentially regulates B7.1 and B7.2 expression on human peripheral blood monocytes.

Authors:  A Clavreul; C L D'hellencourt; C Montero-Menei; G Potron; D Couez
Journal:  Immunology       Date:  1998-10       Impact factor: 7.397

10.  Interleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes.

Authors:  Jacques Thibodeau; Marie-Claude Bourgeois-Daigneault; Gabrielle Huppé; Jessy Tremblay; Angélique Aumont; Mathieu Houde; Eric Bartee; Alexandre Brunet; Marie-Elaine Gauvreau; Aude de Gassart; Evelina Gatti; Martin Baril; Maryse Cloutier; Séverine Bontron; Klaus Früh; Daniel Lamarre; Viktor Steimle
Journal:  Eur J Immunol       Date:  2008-05       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.